In mid-November 2024, the final patient completed AcuCort’s Phase IV clinical trial. Subsequently,...
results
24 January 2025 ChallengerX plc (“ChallengerX”, “CX” or the “Company”) Final...
Saab’s CEO and President Micael Johansson and CFO Anna Wijkander will present...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY...
IFS surpasses €1 billion ARR reinforcing the company’s position as the global...
Issuance of New NotesHeimstaden AB (publ) (“Heimstaden” or the “Company”) today announces...
WIPRO LIMITED AND SUBSIDIARIES
INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
...
Houston, United States:
Fourth-quarter revenue of $9.28 billion increased 1% sequentially...
Heimstaden AB (publ) (“Heimstaden”) announces today the indicative results of its offer to...
VANCOUVER, BC, Jan. 16, 2025 /CNW/ – (TSX: LUN; Nasdaq Stockholm: LUMI)...